{"schema_version":"secwatch.filing_event.v1","accession":"0001453687-23-000061","form_type":"8-K","ticker":"RNAC","cik":"0001453687","company_name":"Cartesian Therapeutics, Inc.","filed_at":"2023-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.983039+00:00","generated_at":"2026-06-10T18:58:52.567731+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"low","headline":"Selecta Biosciences fully repays debt under loan agreement with Oxford Finance and Silicon Valley Bank","bullets":["Paid all outstanding amounts under Loan and Security Agreement dated Aug 31, 2020 (as amended).","Accrued interest and prepayment penalty included; all obligations discharged in full.","All unfunded commitments terminated; liens and security interests automatically released.","Warrants previously issued to Oxford and Silicon Valley Bank remain outstanding.","No financial amounts disclosed; company no longer has debt obligations under this agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001453687-23-000061","json":"https://secwatch.observer/filing/0001453687-23-000061.json","markdown":"https://secwatch.observer/filing/0001453687-23-000061.md","text":"https://secwatch.observer/filing/0001453687-23-000061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000061/0001453687-23-000061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000061/selb-20230911.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T18:58:52.567731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}